A Case of Trousseau Syndrome Responding to Immune Checkpoint Inhibitor Therapy Allowing Long-Term Treatment Continuation
Haigan · 20.04.2026 · 66 (2) · 130-135
DOI: 10.2482/haigan.66.130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haigan, erschienen am 20.04.2026. Verfasst von Maiko Atari und 2 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Background
We report a case in which a patient developed Trousseau syndrome, a paraneoplastic syndrome characterized by recurrent thromboembolic events and associated with a poor prognosis. Notably, this patient, who also had idiopathic pulmonary fibrosis, responded to immune checkpoint inhibitor (ICI) and heparin therapy and was able to continue long-term treatment. Case. A 74-year-old man underwent surgery for left lower lobe lung adenocarcinoma. Recurrence was detected within 2 months after surgery, and ICI therapy was initiated but discontinued due to adverse events. About one year later, the patient presented with visual field defects. An examination confirmed cerebral infarction due to Trousseau syndrome and disease progression. Anticoagulation with heparin was started, and ICI therapy was resumed to treat the underlying disease, resulting in disease control. The patient currently remains clinically stable on this regimen, which includes concomitant oral steroids, with no deterioration in activities of daily living.
Conclusion
Reports of ICI administration for Trousseau syndrome are rare, and to the best of our knowledge, this case represents the first instance in which disease control was maintained for more than 2 years. With the expanding range of treatment options for lung cancer, it is plausible that some patients may exhibit a favorable response to ICI therapy, and we anticipate that further case reports will be published in the future.
Zitieren
APA
Atari, M., Kobayashi, M., & Kawaharada, Y. (2026). A Case of Trousseau Syndrome Responding to Immune Checkpoint Inhibitor Therapy Allowing Long-Term Treatment Continuation. Haigan, 66(2), 130-135. https://doi.org/10.2482/haigan.66.130
Vancouver
Atari M, Kobayashi M, Kawaharada Y. A Case of Trousseau Syndrome Responding to Immune Checkpoint Inhibitor Therapy Allowing Long-Term Treatment Continuation. Haigan. 2026;66(2):130-135. doi:10.2482/haigan.66.130
BibTeX
@article{Atari2026,
author = {Atari, Maiko and Kobayashi, Mirai and Kawaharada, Yasushi},
title = {A Case of Trousseau Syndrome Responding to Immune Checkpoint Inhibitor Therapy Allowing Long-Term Treatment Continuation},
journal = {Haigan},
year = {2026},
volume = {66},
number = {2},
pages = {130--135},
doi = {10.2482/haigan.66.130}
}
EUVIMED